The Efficacy of Nano-water in Combination with Tamsulosin-Dutasteride for Alleviating Lower Urinary Tract Symptoms in Men with Benign Prostatic Hyperplasia
Abstract
Background and Objectives: Symptoms of the Lower urinary tract are common in benign prostatic hyperplasia. This study assessed the effectiveness of Nano-water doubled with tamsulosin-dutasteride in improving these symptoms. Methods: This double-blind, randomized study was conducted in Sulaimani, Iraq, from February 2016 to November 2022. The study included 193 men with an International Prostatic Symptom Score of 13 or higher, peak urine flow rates of 15 milliliters per second or less, and prostatic volumes between 30 and 80 cubic centimeters. The participants were randomly assigned to two groups. Group A (97 men) received Nano-water with tamsulosin-dutasteride, while Group B (96 men) obtained regular water with the same medication. Assessments at baseline and after three months included the International Prostatic Symptom Score, peak urine flow rate, and residual urine volume. Results: Group A demonstrated more remarkable results than Group B. The International Prostatic Symptom Score fell to 6.67 in Group A compared to 10.87 in Group B. Peak urine flow rates climbed to 17.48 milliliters per second in Group A versus 15.45 milliliters per second in Group B. Residual urine was less than 50 milliliters in 88 percent of Group A patients compared to 75 percent in Group B. All results were statistically significant. Conclusions: Nano-water combined with tamsulosin-dutasteride improved lower urinary tract symptoms in men with benign prostate hyperplasia.
How strong is the evidence?
Evidence Hub reads this as a randomized trial, done in people. Its evidence level is 2 of 5 (High · randomized trial). Randomized trials of a reasonable size are the strongest single-study design. Reported size: 193 participants or records.
Read the paper
Related studies
- Treatment of non-metastatic castration-resistant prostate cancer: facing age-related comorbidities and drug–drug interactions
- The Efficacy of Flogofilm® in the Treatment of Chronic Bacterial Prostatitis as an Adjuvant to Antibiotic Therapy: A Randomized Prospective Trial
- Inhibition of growth and contraction in human prostate stromal cells by silencing of NUAK1 and -2, and by the presumed NUAK inhibitors HTH01-015 and WZ4003
- Effectiveness and Safety of a New Nutrient Fixed Combination Containing Pollen Extract Plus Teupolioside, in the Management of LUTS in Patients with Benign Prostatic Hypertrophy: A Pilot Study
- Extract from Cucurbita pepo improves BPH symptoms without affecting sexual function: a 24-month noninterventional study
- Aquablation vs. holmium laser enucleation of the prostate for benign prostatic hyperplasia: a 150-patients prospective comparative multicenter study
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.